Blog - Litchlab

EN

CN

{$ImageUrl,alt}

Blog

Home>Blog

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...

Litchlab Expands CDMO Platform for Mesoporous Silica Nanoparticles to Accelerate Targeted Therapies and Smart Drug Delivery

April 2025 — As precision medicine and advanced drug delivery technologies continue to gain momentum globally, Litchlab proudly announces the expansion of its CDMO platform dedicated to Mesoporous Silica Nanoparticles (MSNs). This platform empowers the develop...

Litchlab Unveils Comprehensive Magnetic Nanoparticle CDMO Services to Empower Precision Medicine and Smart Therapeutics

April 2025 — As the biopharma industry embraces increasingly sophisticated delivery and diagnostic technologies, Litchlab officially launches its full-service Magnetic Nanoparticle (MNP) CDMO Platform. Designed to address the rising demand for precision drug d...

Litchlab Launches Gold Nanoparticle (GNP) Drug Delivery CDMO Services, Advancing Precision Nanomedicine Solutions

April 2025 — Responding to the rising demand for innovative nano-enabled therapeutics, Litchlab today announced the official launch of its Gold Nanoparticle (GNP) Drug Delivery CDMO Platform, offering a comprehensive suite of services from early-stage formulat...

Litchlab Launches Advanced Polymeric Micelle Drug Delivery CDMO Services to Accelerate Next-Generation Therapeutic Innovation

April 2025 — Responding to the global demand for precision drug delivery technologies, Litchlab proudly announces the launch of its Polymeric Micelle Drug Delivery CDMO Platform, offering end-to-end solutions from formulation design, process development, GMP m...

Litchlab Unveils Albumin Nanoparticle CDMO Service Platform, Ushering in a New Era of Precision Drug Delivery

April 25, 2025 — As the demand for smarter, biocompatible, and scalable drug delivery systems grows globally, Litchlab has officially launched its Albumin Nanoparticle Drug Delivery CDMO Service Platform. Designed for innovative biotech and pharma companies, t...

Litchlab Launches Hydrogel Drug Delivery CDMO Services to Build the Next-Gen Precision Delivery Platform

April 2025 — Responding to the global demand for advanced drug delivery systems, Litchlab is proud to announce the launch of its Hydrogel Drug Delivery Technology Platform and CDMO Services, offering end-to-end support from formulation development and process ...

上一页 1 2 3 4 5 下一页